These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22007676)

  • 1. Structure-activity relationships in toll-like receptor 2-agonists leading to simplified monoacyl lipopeptides.
    Agnihotri G; Crall BM; Lewis TC; Day TP; Balakrishna R; Warshakoon HJ; Malladi SS; David SA
    J Med Chem; 2011 Dec; 54(23):8148-60. PubMed ID: 22007676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships in human Toll-like receptor 2-specific monoacyl lipopeptides.
    Salunke DB; Shukla NM; Yoo E; Crall BM; Balakrishna R; Malladi SS; David SA
    J Med Chem; 2012 Apr; 55(7):3353-63. PubMed ID: 22385476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and development of stable, water-soluble, human Toll-like receptor 2 specific monoacyl lipopeptides as candidate vaccine adjuvants.
    Salunke DB; Connelly SW; Shukla NM; Hermanson AR; Fox LM; David SA
    J Med Chem; 2013 Jul; 56(14):5885-900. PubMed ID: 23795818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Evaluation of Novel TLR2 Agonists as Potential Adjuvants for Cancer Vaccines.
    Lu BL; Williams GM; Verdon DJ; Dunbar PR; Brimble MA
    J Med Chem; 2020 Mar; 63(5):2282-2291. PubMed ID: 31418565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-tetradecylcarbamyl lipopeptides as novel agonists for Toll-like receptor 2.
    Willems MM; Zom GG; Khan S; Meeuwenoord N; Melief CJ; van der Stelt M; Overkleeft HS; Codée JD; van der Marel GA; Ossendorp F; Filippov DV
    J Med Chem; 2014 Aug; 57(15):6873-8. PubMed ID: 25019313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, evaluation and molecular dynamics study of human toll-like receptor 2/6 specific monoacyl lipopeptides as candidate immunostimulants.
    Zhu Y; Liu B; Chen Z; Wang X; Wang Y; Zhang W; Wang S; Zhang M; Li Y
    Bioorg Chem; 2023 Dec; 141():106823. PubMed ID: 37708825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships in toll-like receptor-2 agonistic diacylthioglycerol lipopeptides.
    Wu W; Li R; Malladi SS; Warshakoon HJ; Kimbrell MR; Amolins MW; Ukani R; Datta A; David SA
    J Med Chem; 2010 Apr; 53(8):3198-213. PubMed ID: 20302301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunostimulants and Toll-like receptor ligands obtained by screening combinatorial lipopeptide collections.
    Reutter F; Jung G; Baier W; Treyer B; Bessler WG; Wiesmüller KH
    J Pept Res; 2005 Mar; 65(3):375-83. PubMed ID: 15787968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of thiol-reactive lipopeptide adjuvants. Incorporation into liposomes and study of their mitogenic effect on mouse splenocytes.
    Roth A; Espuelas S; Thumann C; Frisch B; Schuber F
    Bioconjug Chem; 2004; 15(3):541-53. PubMed ID: 15149182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR2 agonists and their structure-activity relationships.
    Lu BL; Williams GM; Brimble MA
    Org Biomol Chem; 2020 Jul; 18(27):5073-5094. PubMed ID: 32582902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 6-independent signaling by diacylated lipopeptides.
    Buwitt-Beckmann U; Heine H; Wiesmüller KH; Jung G; Brock R; Akira S; Ulmer AJ
    Eur J Immunol; 2005 Jan; 35(1):282-9. PubMed ID: 15580661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipolanthionine peptides act as inhibitors of TLR2-mediated IL-8 secretion. Synthesis and structure-activity relationships.
    Seyberth T; Voss S; Brock R; Wiesmüller KH; Jung G
    J Med Chem; 2006 Mar; 49(5):1754-65. PubMed ID: 16509590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple synthetic toll-like receptor 2 ligands.
    Abdel-Aal AB; Al-Isae K; Zaman M; Toth I
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5863-5. PubMed ID: 21855334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and immunological evaluation of novel TLR2 agonists through structure optimization of Pam
    Du X; Qian J; Wang Y; Zhang M; Chu Y; Li Y
    Bioorg Med Chem; 2019 Jul; 27(13):2784-2800. PubMed ID: 31101493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural requirement for the agonist activity of the TLR2 ligand Pam2Cys.
    Zeng W; Eriksson E; Chua B; Grollo L; Jackson DC
    Amino Acids; 2010 Jul; 39(2):471-80. PubMed ID: 20091415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Synthetic Lipopeptides as Potential Mucosal Adjuvants Enhanced SARS-CoV-2 rRBD-Induced Immune Response.
    Mao L; Liu C; Liu JY; Jin ZL; Jin Z; Xue RY; Feng R; Li GC; Deng Y; Cheng H; Zou QM; Li HB
    Front Immunol; 2022; 13():833418. PubMed ID: 35356002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic lipopeptide adjuvants and Toll-like receptor 2--structure-activity relationships.
    Spohn R; Buwitt-Beckmann U; Brock R; Jung G; Ulmer AJ; Wiesmüller KH
    Vaccine; 2004 Jun; 22(19):2494-9. PubMed ID: 15193414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A totally synthetic lipopeptide-based self-adjuvanting vaccine induces neutralizing antibodies against heat-stable enterotoxin from enterotoxigenic Escherichia coli.
    Zeng W; Azzopardi K; Hocking D; Wong CY; Robevska G; Tauschek M; Robins-Browne RM; Jackson DC
    Vaccine; 2012 Jul; 30(32):4800-6. PubMed ID: 22634295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and mitigation of acute radiation syndrome in mice by synthetic lipopeptide agonists of Toll-like receptor 2 (TLR2).
    Shakhov AN; Singh VK; Bone F; Cheney A; Kononov Y; Krasnov P; Bratanova-Toshkova TK; Shakhova VV; Young J; Weil MM; Panoskaltsis-Mortari A; Orschell CM; Baker PS; Gudkov A; Feinstein E
    PLoS One; 2012; 7(3):e33044. PubMed ID: 22479357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel glycolipid TLR2 ligands of the type Pam2Cys-α-Gal: synthesis and biological properties.
    Thomann JS; Monneaux F; Creusat G; Spanedda MV; Heurtault B; Habermacher C; Schuber F; Bourel-Bonnet L; Frisch B
    Eur J Med Chem; 2012 May; 51():174-83. PubMed ID: 22483966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.